These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16254400)

  • 1. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.
    Buchert R; Wilke F; Chakrabarti B; Martin B; Brenner W; Mester J; Clausen M
    J Neuroimaging; 2005 Oct; 15(4):348-55. PubMed ID: 16254400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
    Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Dubois A; Hérard AS; Delatour B; Hantraye P; Bonvento G; Dhenain M; Delzescaux T
    Neuroimage; 2010 Jun; 51(2):586-98. PubMed ID: 20206704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints.
    Van Der Gucht A; Verger A; Yagdigul Y; Poussier S; Joly L; Watfa G; Benetos A; Karcher G; Marie PY
    Acta Radiol; 2015 Aug; 56(8):980-9. PubMed ID: 25085109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET.
    von Borczyskowski D; Wilke F; Martin B; Brenner W; Clausen M; Mester J; Buchert R
    Nucl Med Commun; 2006 Sep; 27(9):739-43. PubMed ID: 16894329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.
    Wu X; Chen K; Yao L; Ayutyanont N; Langbaum JB; Fleisher A; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Foster NL; Thompson PM; Harvey DJ; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
    J Neurosci Methods; 2010 Oct; 192(2):277-85. PubMed ID: 20678521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Gallivanone F; Della Rosa PA; Castiglioni I
    Curr Alzheimer Res; 2016; 13(6):682-94. PubMed ID: 26567733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
    Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating the frontal presentation of Alzheimer's disease with FDG-PET.
    Woodward MC; Rowe CC; Jones G; Villemagne VL; Varos TA
    J Alzheimers Dis; 2015; 44(1):233-42. PubMed ID: 25261443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.
    Foster NL; Wang AY; Tasdizen T; Fletcher PT; Hoffman JM; Koeppe RA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S29-36. PubMed ID: 18631997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study.
    Choo IH; Lee DY; Youn JC; Jhoo JH; Kim KW; Lee DS; Lee JS; Woo JI
    Alzheimer Dis Assoc Disord; 2007; 21(2):77-84. PubMed ID: 17545731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of
    Presotto L; Ballarini T; Caminiti SP; Bettinardi V; Gianolli L; Perani D
    Neuroinformatics; 2017 Apr; 15(2):151-163. PubMed ID: 28063108
    [No Abstract]   [Full Text] [Related]  

  • 18. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
    Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
    Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
    Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
    Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
    J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.